← FDA DRUG APPROVALS

FDA ANDA · ANDA070326

INDOMETHACIN

Sponsor: DURAMED PHARMS BARR

APPLICATION
ANDA070326
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-18
LATEST ACTION
1991-01-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

INDOMETHACINDiscontinued
INDOMETHACIN 25MG · CAPSULE · ORAL

Approval history

1991-01-17Labeling · Supplement 14AP
1990-02-06Labeling · Supplement 11AP
1989-06-01Labeling · Supplement 8AP
1989-06-01Labeling · Supplement 7AP
1988-12-19Labeling · Supplement 5AP
1985-10-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →